chr18-77250564-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001480.4(GALR1):c.16G>A(p.Gly6Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000313 in 1,534,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G6W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001480.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALR1 | NM_001480.4 | c.16G>A | p.Gly6Arg | missense_variant | 1/3 | ENST00000299727.5 | |
LOC124904329 | XR_007066422.1 | n.604+284C>T | intron_variant, non_coding_transcript_variant | ||||
GALR1 | XM_017025691.2 | c.16G>A | p.Gly6Arg | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALR1 | ENST00000299727.5 | c.16G>A | p.Gly6Arg | missense_variant | 1/3 | 1 | NM_001480.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152140Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000224 AC: 3AN: 133798Hom.: 0 AF XY: 0.0000412 AC XY: 3AN XY: 72902
GnomAD4 exome AF: 0.0000282 AC: 39AN: 1382054Hom.: 0 Cov.: 36 AF XY: 0.0000308 AC XY: 21AN XY: 681820
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152140Hom.: 0 Cov.: 34 AF XY: 0.0000807 AC XY: 6AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.16G>A (p.G6R) alteration is located in exon 1 (coding exon 1) of the GALR1 gene. This alteration results from a G to A substitution at nucleotide position 16, causing the glycine (G) at amino acid position 6 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at